| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 318.58B | 302.50B | 287.56B | 293.36B | 291.27B |
| Gross Profit | 18.82B | 16.92B | 19.26B | 29.81B | 30.40B |
| EBITDA | 30.90B | 35.47B | 28.61B | 46.35B | 42.42B |
| Net Income | 13.70B | 8.75B | 7.83B | 20.79B | 16.76B |
Balance Sheet | |||||
| Total Assets | 497.32B | 500.67B | 503.39B | 477.01B | 478.15B |
| Cash, Cash Equivalents and Short-Term Investments | 30.91B | 29.92B | 29.92B | 44.89B | 39.87B |
| Total Debt | 111.33B | 110.43B | 98.88B | 101.48B | 117.19B |
| Total Liabilities | 212.18B | 212.90B | 206.97B | 206.63B | 221.84B |
| Stockholders Equity | 283.11B | 285.95B | 294.65B | 266.70B | 252.54B |
Cash Flow | |||||
| Free Cash Flow | 7.41B | -12.79B | -6.50B | 15.25B | 16.48B |
| Operating Cash Flow | 27.62B | 24.45B | 18.50B | 31.02B | 32.14B |
| Investing Cash Flow | -7.73B | -29.11B | -26.80B | -7.70B | -16.78B |
| Financing Cash Flow | -19.32B | 5.18B | -6.18B | -18.58B | -12.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥382.95B | 17.88 | 5.53% | 4.35% | 10.25% | 36.09% | |
73 Outperform | ¥117.61B | 12.80 | ― | 3.57% | 3.07% | -0.96% | |
65 Neutral | ¥23.80B | 11.42 | ― | 2.82% | 2.71% | -5.60% | |
64 Neutral | ¥5.69B | 37.38 | ― | 1.62% | 8.05% | 65.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥255.83B | 14.37 | 4.72% | 1.66% | 5.32% | 71.96% | |
50 Neutral | ¥607.36B | -12.02 | 7.44% | 2.10% | 5.84% | -61.24% |